期刊文献+

SiRNA干扰对高糖环境下大鼠肾小管上皮细胞Toll样受体4/转接子髓分化因子88信号通路的影响 被引量:4

Impact of TLR4-siRNA transfection on the expression of TLR4/MyD88 Signaling in rat tubular epithelial cells under high glucose condition
原文传递
导出
摘要 目的通过siRNA(RNAi)干扰选择性下调TLR4基因的表达,探讨高糖对大鼠肾小管上皮细胞(NRK.52E)T0ll样受体4(toll-like receptor4,TLR4)及其转接子髓分化因子88(myeloid differentiation factor88,MyD88)和炎性因子分泌的影响。方法设计并合成3对针对大鼠TLR4基因的特异性siRNA片段,以带有红色荧光的BLOCK—ITAlexaFluor作为阴性对照,荧光显微镜下观察细胞转染效率,实时定量PCR检测TLR4mRNA的表达变化。挑选基因沉默效率最佳的siRNA用于进一步实验,细胞被分5组:(1)正常糖对照组(NG);(2)高糖组(HG);(3)HG+血管紧张素Ⅱ(AngII)+空转组;(4)HG+AngⅡ+siRNA组;(5)HG+AngⅡ+厄贝沙坦(IrB)组。采用实时定量PCR法检测TLR4、MyD88mRNA的表达,Western印迹检测TLR4、MyD88及核因子kappaB(NF-kB)蛋白表达;ELISA法检测巨噬细胞趋化蛋白1(MCP-1)、白细胞介素6(IL-6)的表达。结果与NG组比较,高糖组TLR4/MyD88mRNA及TLR4、MyD88、NF-kB蛋白表达水平明显上调(均P〈0.01),细胞上清MCP-1、IL-6水平亦升高(P〈0.01);空转组与高糖组比较差异无统计学意义(P〉0.05);SiRNA组、ARB组TLR4、MyD88mRNA明显下调,TLR4、MyD88及NF-kB蛋白明显下调,MCP-1、IL-6表达亦下调(均P〈0.01)。结论高糖上调小管上皮细胞TLR4/MyD88信号及炎性细胞因子表达,Ang11可增强此效应;特异性基因沉默可阻断由高糖及AngII诱导的TLR4信号通路的激活,并下调炎性介质的释放;TLR4信号通路在高糖、高肾素环境肾小管上皮细胞炎性反应机制中发挥关键作用。 Objective To observe the expression of toll like receptor 4(TLR4) Signaling and the release of inflammation factors in rat tubular epithelial cell(NRK-52E) under high glucose condition after TLR4- siRNA transfection. Methods Three TLR4- siRNA sequences were designed and synthesized. The transfection efficiency was observed by fluorescence microscope after transfection, and the expression of TLR4 mRNA was detected by real time PCR. The most effective siRNA was selected to be used for forward experiments. After transfection for 24 h, cells were stimulated with 25 mmol/L glucose and/or 10-7 mmol/L Angiotension ]] (Ang ]I ) for 12 h, 24 h; cells without stimulation were as normal control. Real- time PCR was used to analyze TLR4 and myeloid differentiation factor 88
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2013年第11期837-841,共5页 Chinese Journal of Nephrology
基金 国家自然科学基金项目(81060063) 江西省教育厅科学基金项目(JJJ11354)
  • 相关文献

参考文献18

  • 1Anders HJ, Schlondorff D. Toll- like receptors: emerging concepts in kidney disease. Curr Opin Nephrol, 2007, 16:177 -183.
  • 2Zhang B, Ramesh G, Uematsu S, et al. TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. J Am Soc Nephrol, 2008, 19: 923-932.
  • 3Mora C, Navarro JF. Inflammation and diabetic nephropathy. Curr Diab Rep, 2006, 6: 463-468.
  • 4Marc Y. Donath S. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol, 2011, 2: 95-107.
  • 5吕金雷,丁国华.天然免疫分子在肾脏炎性反应及间质纤维化中的作用[J].中华肾脏病杂志,2007,23(10):685-688. 被引量:9
  • 6Kaur H, Chien A, Jialal I, et al. Hyperglycemia induced Toll like receptor 4 expression and activity in mesangial cells: relevance to diabetic nephropathy. Am J Physiol Renal Physiol, 2012, 30:F1145-F1150.
  • 7吕金雷,贾汝汉,丁国华,陈钦开.血管紧张素Ⅱ通过TLR4-yD88途径诱导大鼠肾小管上皮细胞炎性因子释放[J].中华肾脏病杂志,2010,26(10):780-784. 被引量:7
  • 8Lv J, Jia R, Yang D, et al. Candesartan attenuates Angiotensin II-induced mesangial cell apoptosis via TLR4/MyD88 pathway. Biochem Biophys Res Commun, 2009, 380: 81-86.
  • 9Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia, 1998, 41: 1241-1248.
  • 10Tuttle KR. Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease. J Am Soc Nephrol, 2005,16: 1537-1538.

二级参考文献64

  • 1田少江,丁国华,王桂荣,桂元.表面活性蛋白A在大鼠急性肾盂肾炎动物模型中的表达[J].中华肾脏病杂志,2005,21(8):469-472. 被引量:9
  • 2涂晓文,陈香美.阻断肾素血管紧张素系统对慢性肾脏疾病的治疗作用[J].中华肾脏病杂志,2006,22(1):54-56. 被引量:43
  • 3田少江,丁国华,陈铖,贾俊亚,梁伟.表面活性蛋白A调节肾小管上皮细胞巨噬细胞炎症蛋白2的表达及其机制的探讨[J].中华肾脏病杂志,2006,22(5):303-306. 被引量:1
  • 4Volpe M,Ruilope LM,McInnes GT,et al.Angiotensin-Ⅱ receptor blockers:benefits beyond blood pressure reduction?J Hum Hypertens,2005,19:331-339.
  • 5Kondo S,Shimizu M,Urushihara M,et al.Addition of the antioxidant probucol to angiotensin Ⅱ type Ⅰ receptor antagonist arrests progressive mesangioproliferative glomerulonephritis in the rat.J Am Soc Nephrol,2006,17:783-794.
  • 6Satoh M,Fujimoto S,Arakawa S,et al.Angiotensin Ⅱ type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy.Nephrol Dial Transplant,2008,23:3806-3813.
  • 7Anders HJ,Schlondorff D.Toll-like receptors:emerging concepts in kidney disease.Curr Opin Nephrol Hypertens,2007,16:177-183.
  • 8Lv J,Jia R,Yang D,et al.Candesartan attenuates angiotensin Ⅱ-induced mesangial cell apoptesis via TLR4/MyD88 pathway.Biochem Biophys Res Commun,2009,380:81-86.
  • 9Satoh M,Kashiham N,Yamasaki Y,et al.Renal interstitial fibrosis is reduced in angiotensin Ⅱ type la receptor-deficient mice.J Am Soc Nephrol,2001,12:317-325.
  • 10Rastaldi MP,Ferrario F,Giantino L,et al.Epithelialmesenchymal transition of tubular epithelial cells in human renal biopsies.Kidney Int,2002,62:137-146.

共引文献16

同被引文献59

  • 1徐惠,官阳,杨木兰,周泽斌,张春明.PDGF及PDGFR在大鼠肾间质纤维化过程中的作用[J].中国现代医学杂志,2007,17(19):2354-2358. 被引量:18
  • 2Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate inmmune system?[J]. Diabetologia, 1998, 41(10): 1241-1248.
  • 3Navarro- Gonz61ez JF, Mora- Fernandez C, Muros de Fuentes M, et al. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy[J]. Nat Rev Nephrol, 2011, 7(6) : 327- 340. DOI: 10.1038/nmeph.2011.51.
  • 4Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy[J]. Clin Sci (London), 2013, 124(3): 139- 152. DOI: 10.1042/CS20120198.
  • 5Leoncini G, Viazzi F, Pontremoli R. RAAS inhibition and renal protection[J]. Curr Pharm Des, 2012, 18(7): 971-980.
  • 6White SL, Cass A, Atkins RC, et al. Chronic kidney disease in the general population[J]. Adv Chronic Kidney Dis, 2005, 12 (1): 5-13.
  • 7Dasu MR, Devaraj S, Park S, et al. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects[J]. Diabetes Care, 2010, 33(4): 861- 868. DOI: 10.2337/de09-1799.
  • 8Kaur H, Chien A, Jialal I. Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy[J]. Am J Physiol Renal Physiol, 2012, 303(8): F1145- F1150. DOI: 10.1152/ajprenal. 00319.2012.
  • 9Lin M, Yiu WH, Wu H J, et al. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy[J]. J Am Soc Nephrol, 2012, 23(1): 86-102. DOI: 10.1681/ASN.2010111210.
  • 10Ma J, Chadban S J, Zhao CY, et al. TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy [J]. PLoS One, 2014, 9(5): e97985. DOI: 10.1371/journal. pone.0097985.

引证文献4

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部